First Time Loading...
N

Nordhealth AS
OSE:NORDH

Watchlist Manager
Nordhealth AS
OSE:NORDH
Watchlist
Price: 33.7 NOK 2.74% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Nordhealth AS?
Write Note

Intrinsic Value

Nordhealth AS is a cloud-based healthcare software-as-a-service company. [ Read More ]

The intrinsic value of one NORDH stock under the Base Case scenario is 172.13 NOK. Compared to the current market price of 33.7 NOK, Nordhealth AS is Undervalued by 80%.

Key Points:
NORDH Intrinsic Value
Base Case
172.13 NOK
Undervaluation 80%
Intrinsic Value
Price
N
Base Case Scenario

Valuation Backtest
Nordhealth AS

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NORDH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nordhealth AS

Current Assets 33.4m
Cash & Short-Term Investments 27.5m
Receivables 4.8m
Other Current Assets 1m
Non-Current Assets 64.8m
Long-Term Investments 834k
PP&E 573k
Intangibles 62.8m
Other Non-Current Assets 615k
Current Liabilities 9.9m
Accounts Payable 869k
Accrued Liabilities 4.2m
Other Current Liabilities 4.8m
Non-Current Liabilities 270k
Other Non-Current Liabilities 270k
Efficiency

Earnings Waterfall
Nordhealth AS

Revenue
35.2m EUR
Cost of Revenue
-5.1m EUR
Gross Profit
30.1m EUR
Operating Expenses
-41.9m EUR
Operating Income
-11.9m EUR
Other Expenses
-148k EUR
Net Income
-12m EUR

Free Cash Flow Analysis
Nordhealth AS

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NORDH Profitability Score
Profitability Due Diligence

Nordhealth AS's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative ROE
33/100
Profitability
Score

Nordhealth AS's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

NORDH Solvency Score
Solvency Due Diligence

Nordhealth AS's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
79/100
Solvency
Score

Nordhealth AS's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NORDH Price Targets Summary
Nordhealth AS

Wall Street analysts forecast NORDH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NORDH is 42.84 NOK with a low forecast of 42.42 NOK and a high forecast of 44.1 NOK.

Lowest
Price Target
42.42 NOK
26% Upside
Average
Price Target
42.84 NOK
27% Upside
Highest
Price Target
44.1 NOK
31% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NORDH Price
Nordhealth AS

1M 1M
-3%
6M 6M
+48%
1Y 1Y
+35%
3Y 3Y
-23%
5Y 5Y
-14%
10Y 10Y
-14%
Annual Price Range
33.7
52w Low
21.1
52w High
34.9
Price Metrics
Average Annual Return -22.16%
Standard Deviation of Annual Returns 27.08%
Max Drawdown -65%
Shares Statistics
Market Capitalization 2.7B NOK
Shares Outstanding 79 045 109
Percentage of Shares Shorted
N/A

NORDH Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nordhealth AS

Country

Norway

Industry

Health Care

Market Cap

2.7B NOK

Dividend Yield

0%

Description

Nordhealth AS is a cloud-based healthcare software-as-a-service company. The company is headquartered in Molde, More Og Romsdal. The company went IPO on 2021-06-03. The firm's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.

Contact

MORE OG ROMSDAL
Molde
Eikremsvingen 9
+4723111111

IPO

2021-06-03

Employees

189

Officers

Chief Executive Officer
Mr. Charles MacBain
Chief Financial Officer
Ms. Mari Orttenvuori
Chief People Officer
Ms. Hanna Chiorazzo
Chief Innovation Officer of Veterinary & Board Member
Mr. Janne Heikki Huttunen

See Also

Discover More
What is the Intrinsic Value of one NORDH stock?

The intrinsic value of one NORDH stock under the Base Case scenario is 172.13 NOK.

Is NORDH stock undervalued or overvalued?

Compared to the current market price of 33.7 NOK, Nordhealth AS is Undervalued by 80%.